Dimensional Fund Advisors
SONM icon

Dimensional Fund Advisors’s DNA X Inc SONM Stock Holding History

Dimensional Fund Advisors’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-873
Closed -$33.6K – 3328
2025
Q1 		$33.6K Sell
873
-22
-2% -$1.05K ﹤0.01% 3279
2024
Q4 		$50.9K Hold
895
– – ﹤0.01% 3290
2024
Q3 		$46.7K Buy
+895
New +$56.2K ﹤0.01% 3305

Other funds holding SONM

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Dimensional Fund Advisors's SONM Position: Q2 2025 in Review

Dimensional Fund Advisors sold out of DNA X Inc (SONM) in Q2 2025, closing a stake of 873 shares — an estimated $33.6K sold.

Dimensional Fund Advisors first reported a position in SONM in Q3 2024 and held it in 3 quarters. The position peaked at $50.9K in Q4 2024. 18 funds tracked by Wall St. Rank hold SONM as of Q2 2025.

  • Dimensional Fund Advisors reported no remaining DNA X Inc position as of Q2 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 873 DNA X Inc shares in Q2 2025, an estimated $33.6K.
  • Dimensional Fund Advisors first reported a position in DNA X Inc in Q3 2024 and held it in 3 quarters.
  • Dimensional Fund Advisors's DNA X Inc position peaked at $50.9K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2025.

Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.